Novo Nordisk Lobbies Up to Win Medicare Coverage of Its Weight Loss Drugs
The maker of Ozempic and Wegovy has recently hired a dozen new lobbyists to work on the issue of obesity and medication coverage.
The maker of Ozempic and Wegovy has recently hired a dozen new lobbyists to work on the issue of obesity and medication coverage.
Recent academic studies have found that private equity investment is rushing in to for-profit healthcare companies, but patients may not benefit.
Half of lower-income Americans face cost barriers to getting health care, according to a new report from the Commonwealth Fund.